Home » OptoVue Gets Clearance for Blood Vessel Measurement Device
OptoVue Gets Clearance for Blood Vessel Measurement Device
June 13, 2018
Fremont, California based OptoVue received 510(k) clearance from the FDA for its AngioAnalytics optical coherence tomography angiography blood vessel measurement technology.
The device provides high-resolution imaging of retinal blood vessels and is designed to help manage diseases that cause progressive blindness.
The platform analyzes areas where blood vessel loss and abnormal blood vessel growth occurs, as well as other parameters needed to assess changes to the foveal avascular zone.
Upcoming Events
-
21Oct